This work was funded by the National Key Research and Development Program of China (2017YFC1703904), the University (Chengdu University of TCM) - enterprise (Tibet Rhodiola Pharmaceutical Holding Co. LTD) cooperation project (1052022040101); the Regional Innovation and Cooperation Project of the Science &#38; Technology Department of Sichuan Province (2020YFQ0032); and the Key R&#38;D and Transformation Program of the Science &#38; Technology Department of Qinghai Province (2020-SF-C33).

1. Solution preparation
<ol>
	<li>Prepare the reference substance stock solution: Weigh 10.6 mg of salidroside, 5.24 mg of gallic acid, and 5.21 mg of ethyl gallic acid separately on an electronic analytical balance and add them individually into a 5 mL volumetric flask. Then, add HPLC-grade methanol to dissolve and dilute to 5 mL. Finally, shake well to obtain the reference substance stock solution with mass concentrations of 2.120 mg/mL, 1.048 mg/mL, and 1.042 mg/mL, respectively. 
	NOTE: The reference substance stock solution contains 2.120 mg/mL salidroside, 1.048 mg/mL gallic acid, and 1.042 mg/mL ethyl gallate as the stock solution of each solution in the subsequent standard curve.</li>
	<li>Prepare the test sample solution. Extract 2.8 g of RG (Table of Materials) with 10 mL of HPLC-grade methanol using an ultrasonic cleansing machine (Power: 200 W, frequency: 40 kHz) for 30 min, and then filter it with a 0.22 &#181;m filter for the system adaptability test.</li>
	<li>Prepare a mixed reference solution that contains 0.590 mg/mL salidroside, 2.030 mg/mL gallic acid, and 1.930 mg/mL ethyl gallate. 
	NOTE: Each standard (2.950 mg of salidroside, 10.150 mg of gallic acid, and 9.650 mg of ethyl gallic acid) is dissolved in a 5 mL volumetric flask in HPLC-grade methanol as the dissolution medium.</li>
	<li>Obtain the theoretical content of each characteristic component of RG for ultrapure water extraction.
	<ol>
		<li>Place 2.8 g of RG in a 500 mL conical flask, add 200 mL of ultrapure water, and ultrasonically extract (Power: 200 W, frequency: 40 kHz) for 60 min. Then, filter it with a 0.22 &#181;m filter.</li>
		<li>Determine the content of the test solution according to the linear equation obtained in the following experiment.</li>
	</ol>
	</li>
</ol>
2. Chromatographic condition
<ol>
	<li>Set the chromatographic conditions as shown in Table 1 for high-performance liquid chromatography. For details about the instrument used, refer to the Table of Materials.</li>
</ol>
3. System adaptability test
<ol>
	<li>Investigate the linear relationship.
	<ol>
		<li>Dilute the reference stock solutions of gallic acid and ethyl gallate by 5, 10, 25, 50, and 125 times, and the reference stock solutions of salidroside by 2, 4, 8, 16, and 32 times to obtain the gradient concentration solution for drawing a standard curve. 
		NOTE: Adjust the dilution ratio of the standard curve according to the preliminary experiment of the sample treatment. In the preliminary experiment, the stock solutions of the three standards were first diluted 5, 10, 25, 50, and 125 times, and then the first standard curve was plotted. However, when the concentration of the test sample was detected, it was found that the concentrations of salidroside did not fall within the linear range of this standard curve and, therefore, the concentrations were adjusted to include them in the curve. In summary, the above preliminary experiments were used to determine the final dilution concentrations of the three test samples for subsequent experimental studies.</li>
	</ol>
	</li>
	<li>Precision testing: Inject 10 &#181;L of the mixed reference solution into the HPLC system six times daily and run the samples with the same HPLC conditions described in step 2.1. Record the peak area of each feature component.</li>
	<li>Stability testing experiments: Inject 10 &#181;L of the prepared sample solution and determine the peak areas of the HPLC according to the chromatographic conditions after 0 h, 6 h, 10 h, 12 h, 14 h, 16 h, 18 h, 20 h, and 24 h, respectively. 
	NOTE: The peak areas are recorded automatically by the HPLC system.</li>
	<li>Reproducibility test: Take six samples of the same batch of RG to prepare the test sample solution according to the method in step 1.2. Inject 10 &#181;L of each sample into the HPLC system. Run the samples as described in step 2.1 and determine reproducibility. 
	NOTE: Repeatability was evaluated by comparing the concentration differences between the six samples.</li>
	<li>Recovery experiment
	<ol>
		<li>Prepare six portions of the same batch of RG for the test solution. Then, add about 50% of the reference substance of each index component in the test solution to calculate the recovery rate. Run these samples in the HPLC system with the same conditions described in step 2.1.</li>
		<li>Calculate the recovery rate. 
		&#8203;NOTE: Recovery rate = (C - A) / B x 100, where A is the amount of component to be measured in the test solution, B is the amount of reference substance added, and C is the measured value of the solution containing the reference substance and the RG sample. Refer to step 2.1 for the chromatographic conditions to perform the above steps (i.e., steps 3.1-3.5).</li>
	</ol>
	</li>
</ol>
4. In vitro dissolution test
<ol>
	<li>Carry out the dissolution test using the paddle method of the second method of general rule 0931 from Chinese Pharmacopoeia (2020 edition)12. 
	NOTE: Sampling technique and equipment: The drug dissolution apparatus (Table of Materials) has a dissolution cup, a paddle, a temperature control system, and a speed adjustment system. Before starting the dissolution experiment, the water is preheated to a set temperature, and then the corresponding speed is set. Start recording the time immediately after adding RG.</li>
	<li>Add 100 mL of ultrapure water into the dissolution cup of the drug dissolution apparatus and maintain the temperature at 37 &#176;C &#177; 0.5 &#176;C. Set the rotation speed to 100 rpm. 
	NOTE: The dissolution apparatus has a heating device that allows the temperature to be set within the system. There was no significant difference in the dissolution rate of salidroside in water, artificial gastric juice (16.4 mL of diluted hydrochloric acid [234 mL of concentrated hydrochloric acid diluted to 1000 mL with water] with about 800 mL of water and 10 g of pepsin, well shaken, and diluted with water to 1,000 mL), and artificial intestinal juice (phosphate buffer [pH 6.8] containing trypsin)13. The most readily available water (ultrapure) was selected as the dissolution medium.</li>
	<li>Add 2.8 g of RG into a dissolution cup and start recording the duration of dissolution immediately. Collect a total of 1 mL of the sample with an injector (see Table of Materials) at 1 min, 5 min, 10 min, 20 min, 30 min, and 60 min, and make up the volume in the dissolution cup with the dissolution medium at the same temperature immediately. 
	NOTE: The sampling tube in the dissolution cup cannot collect small sample volumes, so the injector is used to collect the sample. Samples must be collected quickly to avoid missing specified collection time points.</li>
	<li>Immediately filter the collected samples through a 0.22 &#181;m microporous membrane and take the subsequent filtrate. Determine the content of each component at each time point by HPLC (as per step 2.1) and calculate the cumulative dissolution.
	<ol>
		<li>To calculate the cumulative dissolution, calculate the dissolution of each time point (Xn): 
		Xn = A / B x 100, where A is the quantity of components measured at each time point and B is the theoretical content of each component.</li>
		<li>Then, calculate the cumulative dissolution (Y): 
		Y = Xn + (X1 + ... + Xn-1) x V2 / V1, where V1 is the total volume of the dissolution medium and V2 is the volume of solute added after each sampling. 
		&#8203;NOTE: Due to the low response values of salidroside and gallic acid in the chromatogram, the cumulative dissolution of salidroside and ethyl gallate at the 1 min time point was not plotted in the dissolution curve.</li>
	</ol>
	</li>
</ol>
5. Fitting the dissolution model
<ol>
	<li>Import the cumulative dissolution data at each time point into the data analysis software.</li>
	<li>Use the drug dissolution analysis plug-in in the data analysis software to fit the GompertzMod equation, the Gompertz equation, the Logistic equation, and the Weibull equation14. The larger the value of R2, the better the curve-fitting effect is.
	<ol>
		<li>Start the software, select the Book1 window to enter the Origin Data Editing window.</li>
		<li>In the first column A(X)-Long Name input Time, define Time as time, and input each dissolution determination time. Input Data in the second column B(Y)-Long Name, define Data as the cumulative dissolution, input the cumulative dissolution percentage of each dissolution determination time.</li>
		<li>After data input, select the column A(X) and B(Y), and select the Drug Dissolution Analysis plug-in in the software menu bar and click on Fit Dissolution Data &#62; Concatenate Fit &#62; OK. The software generates the fitting results of each model.</li>
	</ol>
	</li>
</ol>

<ol>
	<li>Smith, S. C., Zheng, Z. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+impending+cardiovascular+pandemic+in+China.">The impending cardiovascular pandemic in China.</a> Circulation Cardiovascular Quality and Outcomes. 3 (3), 226-227 (2010).</li><li>Wang, D., Wang, P., Zhang, R., Xi, X. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Efficacy+and+safety+of+Xuefu+Zhuyu+decoction+combined+with+Western+medicine+for+angina+pectoris+in+coronary+heart+disease:+A+protocol+for+systematic+review+and+meta-analysis.">Efficacy and safety of Xuefu Zhuyu decoction combined with Western medicine for angina pectoris in coronary heart disease: A protocol for systematic review and meta-analysis.</a> Medicine. 99 (50), 23195 (2020).</li><li>Yang, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+role+of+traditional+Chinese+medicine+in+the+regulation+of+stress+in+treating+coronary+heart+disease.">The role of traditional Chinese medicine in the regulation of stress in treating coronary heart disease.</a> Oxidative Medicine and Cellular Longevity. 2019, 3231424 (2019).</li><li>Yang, J., Tian, S., Zhao, J., Zhang, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Exploring+the+mechanism+of+TCM+formulae+in+the+treatment+of+different+types+of+coronary+heart+disease+by+network+pharmacology+and+machining+learning.">Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning.</a> Pharmacological Research. 159, 105034 (2020).</li><li>Pu, W. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Anti-inflammatory+effects+of+Rhodiola+rosea+L.:+A+review.">Anti-inflammatory effects of Rhodiola rosea L.: A review.</a> Biomedicine &amp; Pharmacotherapy. 121, 109552 (2020).</li><li>Tao, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rhodiola+species:+A+comprehensive+review+of+traditional+use,+phytochemistry,+pharmacology,+toxicity,+and+clinical+study.">Rhodiola species: A comprehensive review of traditional use, phytochemistry, pharmacology, toxicity, and clinical study.</a> Medicinal Research Reviews. 39 (5), 1779-1850 (2019).</li><li>Li, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Exploring+the+biochemical+basis+of+the+meridian+tropism+theory+for+the+qi-invigorating+traditional+Chinese+medicine+herb+Panax+ginseng.">Exploring the biochemical basis of the meridian tropism theory for the qi-invigorating traditional Chinese medicine herb Panax ginseng.</a> Journal of Evidence-Based Integrative Medicine. 26, 2515690 (2021).</li><li>Pang, Y., Liang, J. Q. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Effect+of+Nordicam+on+hemodynamics+in+rats+with+myocardial+ischemia-reperfusion+injury.">Effect of Nordicam on hemodynamics in rats with myocardial ischemia-reperfusion injury.</a> Journal of Chinese Medicinal Materials. 36 (2), 276-279 (2013).</li><li>Nickerson, B., Kong, A., Gerst, P., Kao, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Correlation+of+dissolution+and+disintegration+results+for+an+immediate-release+tablet.">Correlation of dissolution and disintegration results for an immediate-release tablet.</a> Journal of Pharmaceutical and Biomedical Analysis. 150, 333-340 (2018).</li><li>Kambayashi, A., Yomota, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Exploring+clinically+relevant+dissolution+specifications+for+oral+solid+dosage+forms+of+weak+acid+drugs+using+an+in+silico+modeling+and+simulation+approach.">Exploring clinically relevant dissolution specifications for oral solid dosage forms of weak acid drugs using an in silico modeling and simulation approach.</a> European Journal of Pharmaceutical Sciences. 159, 105728 (2021).</li><li>Meng, S., Jiang, T. Y., Bu, C. J., Liu, J. Q. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Research+progress+on+the+dissolution+of+traditional+Chinese+medicine+preparations.">Research progress on the dissolution of traditional Chinese medicine preparations.</a> Chinese Journal of Clinical Rational Drug Use. 8 (32), 180-181 (2015).</li><li>Chinese Pharmacopoeia Committee. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=.">.</a> Pharmacopoeia of the People's Republic of China. 4, (2020).</li><li>Lin, J. Z. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=.">.</a> Evaluation on Pre-Preparation of Rhodiola Extract. , (2013).</li><li>Zhou, Y. B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Calculation+of+drug+solubility+Weibull+distribution+parameters+by+Origin+software.">Calculation of drug solubility Weibull distribution parameters by Origin software.</a> Herald of Medicine. 30 (06), 721-723 (2011).</li><li>Hu, C. Q., Pan, R. X. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Progress+in+evaluation/prediction+of+bioequivalence+of+solid+oral+preparations+by+dissolution+test.">Progress in evaluation/prediction of bioequivalence of solid oral preparations by dissolution test.</a> Chinese Journal of New Drugs. 23 (01), 44-51 (2014).</li><li>Zhang, H., Yu, L. X. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Dissolution+testing+for+solid+oral+drug+products:+Theoretical+considerations.">Dissolution testing for solid oral drug products: Theoretical considerations.</a> American Pharmaceutical Review. 7 (5), 26-30 (2004).</li><li>Ren, J. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Analytical+strategies+for+the+discovery+and+validation+of+quality-markers+of+traditional+Chinese+medicine.">Analytical strategies for the discovery and validation of quality-markers of traditional Chinese medicine.</a> Phytomedicine. 67, 153165 (2020).</li><li>Li, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Establishment+of+modified+biopharmaceutics+classification+system+absorption+model+for+oral+Traditional+Chinese+Medicine+(Sanye+Tablet).">Establishment of modified biopharmaceutics classification system absorption model for oral Traditional Chinese Medicine (Sanye Tablet).</a> Journal of Ethnopharmacology. 244, 112148 (2019).</li><li>Song, X. Y., Li, Y. D., Shi, Y. P., Jin, L., Chen, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Quality+control+of+traditional+Chinese+medicines:+a+review.">Quality control of traditional Chinese medicines: a review.</a> Chinese Journal of Natural Medicines. 11 (6), 596-607 (2013).</li><li>Wu, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Quality+markers+based+on+biological+activity:+A+new+strategy+for+the+quality+control+of+traditional+Chinese+medicine.">Quality markers based on biological activity: A new strategy for the quality control of traditional Chinese medicine.</a> Phytomedicine. 44, 103-108 (2018).</li><li>Wei, N. -. N., Wang, X., Su, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Progress+of+dissolution+test+methodologies.">Progress of dissolution test methodologies.</a> Chinese Journal of New Drugs. 22 (10), 1119-1124 (2013).</li><li>Chi, Z., Azhar, I., Khan, H., Yang, L., Feng, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Automatic+dissolution+testing+with+high-temporal+resolution+for+both+immediate-release+and+fixed-combination+drug+tablets.">Automatic dissolution testing with high-temporal resolution for both immediate-release and fixed-combination drug tablets.</a> Scientific Reports. 9 (1), 17114 (2019).</li><li>Haidar, S. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Bioequivalence+approaches+for+highly+variable+drugs+and+drug+products.">Bioequivalence approaches for highly variable drugs and drug products.</a> Pharmaceutical Research. 25 (1), 237-241 (2008).</li></ol>

The authors have nothing to disclose.

The dissolution test is an ideal in vitro method to simulate the disintegration and dissolution of solid oral preparations in the gastrointestinal tract15. It is an important index for evaluating and controlling the quality of solid oral preparations. Therefore, the dissolution test plays an essential role in the development of solid drug oral preparations16. In particular, with the development of traditional Chinese medicine (TCM) quality control technology, the d...

In China, the prevalence of cardiovascular diseases continues to rise, and the morbidity and mortality rates of cardiovascular diseases rank first among Chinese residents1. Angina pectoris of coronary heart disease is caused by luminal stenosis due to coronary atherosclerosis, which leads to relatively insufficient coronary blood supply and myocardial ischemia and hypoxia2. In recent years, the curative effect of traditional Chinese medicine in the treatment of coronary heart disease has been recognized by many doctors3.
Traditional Chinese medicine plays an important role in alleviating clinical symptoms and improving the quality of life of patients4. Rhodiola granules (RG) are extracted and refined from the Tibetan Plateau medicinal plant Rhodiola rosea L. The main components of RG are salidroside, rhodiosin, and flavonoids5,6. RG has the effect of supplementing Qi7 and activating and promoting blood circulation to relieve pain. Clinically, it is used to treat chest obstructions caused by Qi deficiency and blood stasis, coronary heart disease, angina pectoris8. Content determination alone does not fully reflect the intrinsic quality of the drugs, as both the disintegration and dissolution in vitro can affect the bioavailability and efficacy of the drugs9,10. The inspection methods for the dissolution of Chinese medicine include the rotating basket method, the paddle method, and the small cup method. The disadvantage of the rotating basket method is that only the outer part of the rotating basket comes in contact with the dissolution medium during rotation, which does not reflect the real-world dissolution behavior. The paddle method can overcome the above shortcoming, which makes it more suitable than the basket method for some solid Chinese medicine preparations11. At present, there is no report on the in vitro dissolution analysis of RG. In order to control the quality of RG more comprehensively, the dissolution behavior of the three index components (gallic acid, salidroside, and ethyl gallate) in RG was investigated. This study provides data for the quality control of RG and a methodological reference for quality evaluation of other ethnic compound preparations.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>Chromatographic column</td>
			<td>ZORBAX Eclipse&#160;&#160;</td>
			<td>XDB-C18</td>
			<td>4.6 mm x 250 mm, 5 &#181;m</td>
		</tr>
		<tr>
			<td>Drug dissolution tester</td>
			<td>Shanghai Huanghai Pharmaceutical Inspection Instrument Co., Ltd.</td>
			<td>RCZ-6B3</td>
			<td></td>
		</tr>
		<tr>
			<td>Electronic analytical balance</td>
			<td>Shanghai Liangping Instruments Co., Ltd.</td>
			<td>FA1004</td>
			<td></td>
		</tr>
		<tr>
			<td>Ethyl gallate (HPLC, &#8805;98%)</td>
			<td>Chengdu Desite Biotechnology Co., Ltd.</td>
			<td>DSTDM006301</td>
			<td></td>
		</tr>
		<tr>
			<td>Function drawing software</td>
			<td>OriginLab Corporation, Northampton, MA, USA</td>
			<td>2022</td>
			<td></td>
		</tr>
		<tr>
			<td>Gallic acid (HPLC, &#8805;98%)</td>
			<td>Chengdu Desite Biotechnology Co., Ltd.</td>
			<td>DSTDM000802</td>
			<td></td>
		</tr>
		<tr>
			<td>High performance liquid chromatography</td>
			<td>Agilent Technologies Singapore (International) Pte. Ltd.</td>
			<td>Agilent 1260 Infinity <img alt="Equation 1" src="/files/ftp_upload/64670/64670eq01.jpg" style="margin: auto;" /></td>
			<td></td>
		</tr>
		<tr>
			<td>HPLC grade methanol</td>
			<td>Thermo Fisher Scientific (China) Co., Ltd.</td>
			<td>216565</td>
			<td></td>
		</tr>
		<tr>
			<td>Injector</td>
			<td>Chengdu Xinjin Shifeng Medical Apparatus &#38; Instrument Co., Ltd.</td>
			<td>0.7 (22 G)</td>
			<td></td>
		</tr>
		<tr>
			<td>Millipore filter</td>
			<td>Tianjin Jinteng Experimental Equipment Co., Ltd</td>
			<td>&#966;13 0.22 Nylon66</td>
			<td></td>
		</tr>
		<tr>
			<td>Rhodiola granules</td>
			<td>Tibet Nodikang Pharmaceutical Co., Ltd.</td>
			<td>210501</td>
			<td></td>
		</tr>
		<tr>
			<td>Salidroside (HPLC, &#8805;98%)</td>
			<td>Chengdu Desite Biotechnology Co., Ltd.</td>
			<td>DST200425-037</td>
			<td></td>
		</tr>
		<tr>
			<td>Ultra pure water systemic</td>
			<td>Merck Millipore Ltd.</td>
			<td>Milli-Q</td>
			<td></td>
		</tr>
		<tr>
			<td>Ultrasonic cleansing machine</td>
			<td>Ningbo Xinyi Ultrasonic Equipment Co., Ltd</td>
			<td>SB-8200 DTS</td>
			<td></td>
		</tr>
	</tbody>
</table>

an in vitro dissolution determination of multi-index components in tibetan medicine rhodiola granules

The composition of the Tibetan medicine Rhodiola granules (RG) is complex, and the overall quality of RG is difficult to determine. Therefore, establishing a method to determine the multi-component in vitro dissolution of RG is of great significance for quality control. This study uses the second paddle method of the fourth general rule 0931 from the Chinese Pharmacopoeia (2020 edition), compliant with apparatus 2 of the United States Pharmacopeia (USP). The dissolution apparatus was set to a rotation speed of 100 rpm with ultrapure water as the dissolution medium. A sample volume of 1 mL was collected at each timepoint. Furthermore, the cumulative dissolution of gallic acid, salidroside, and ethyl gallic acid in RG at different time points was determined by high-performance liquid chromatography (HPLC). Finally, the dissolution curves were drawn, and the curves were fitted to the GompertzMod, the Gompertz, the Logistic, and the Weibull equations. The results showed that the cumulative dissolution of gallic acid in RG was over 80% at 1 min, the cumulative dissolution of salidroside and ethyl gallic acid was over 65% at 5 min, and the cumulative dissolution of each index component decreased after 30 min. The curve fitting demonstrated that the GompertzMod equation was the best-fitting model for each index component of RG. In conclusion, the dissolution test method described in this protocol is simple, accurate, and reliable. It can characterize the dissolution behavior of the index components in RG in vitro, which provides a methodological reference for quality control of RG and quality evaluation of other ethnic compounds.

In this study, the precision, stability, repeatability, and sample recovery of RG were all within the methodological range specified in Chinese Pharmacopoeia (Volume 4, 2020)12, indicating that the method was feasible. After repeated debugging, it was determined that the elution gradient used in this study had good resolution (Figure 1) for the three index components in RG. The three index components in RG had a good linear relationship within a specific concentration...

Watch this Scientific Journal Video about An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules at JoVE.com

An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules

Here, we test the dissolution of Rhodiola granules (RG) in vitro, draw dissolution curves of salidroside, gallic acid, and ethyl gallate in ultrapure water, and fit the curves to different mathematical models. This protocol provides information and guidance for in vivo bioequivalence and in vivo-in vitro correlation studies of RG.

An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules

The composition of the Tibetan medicine Rhodiola granules (RG) is complex, and the overall quality of RG is difficult to determine. Therefore, ...

an-vitro-dissolution-determination-multi-index-components-tibetan

Research

Education

JoVE Core

JoVE Journal

Pharmacokinetics and Pharmacodynamics

Medicine

Unit 1

Pharmacokinetics: Drug Absorption

SCIENTISTS IN ACTION

1.6K ビュー.  Chengdu University of Traditional Chinese Medicine. in vitro測定は、薬物崩壊の影響、溶解挙動、および有効成分の含有量を考慮した固形漢方薬製剤の溶液の溶解を検査するのに適した尺度です。マルチインデックス成分の検出は、中立的な影響と異なる成分の溶解差をよりよく反映することができます。手順を実演するのは、私の研究室の並外れた学生であるQuinyun Duです。はじめに、電子分析天びん上で10.6ミリグラ...

ビデオ: An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules

Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model

Stem cell transplantation protocols are finding their way into clinical practice1,2,3. Getting better results, making the protocols more robust, and finding new sources for implantable cells are the focus of recent research4,5. Investigating the effectiveness of cell therapies is not an easy task and new tools are needed to investigate the mechanisms involved in the treatment process6. We designed an experimental protocol of ischemia/reperfusion in order to allow the observation of cellular connections and even subcellular mechanisms during ischemia/reperfusion injury and after stem cell transplantation and to evaluate the efficacy of cell therapy. H9c2 cardiomyoblast cells were placed onto cell culture plates7,8. Ischemia was simulated with 150 minutes in a glucose free medium with oxygen level below 0.5%. Then, normal media and oxygen levels were reintroduced to simulate reperfusion. After oxygen glucose deprivation, the damaged cells were treated with transplantation of labeled human bone marrow derived mesenchymal stem cells by adding them to the culture. Mesenchymal stem cells are preferred in clinical trials because they are easily accessible with minimal invasive surgery, easily expandable and autologous. After 24 hours of co-cultivation, cells were stained with calcein and ethidium-homodimer to differentiate between live and dead cells. This setup allowed us to investigate the intercellular connections using confocal fluorescent microscopy and to quantify the survival rate of postischemic cells by flow cytometry. Confocal microscopy showed the interactions of the two cell populations such as cell fusion and formation of intercellular nanotubes. Flow cytometry analysis revealed 3 clusters of damaged cells which can be plotted on a graph and analyzed statistically. These populations can be investigated separately and conclusions can be drawn on these data on the effectiveness of the simulated therapeutical approach.

Stem Cell Transplantation in an in vitro Simulated Ischemia/Reperfusion Model

We demonstrate how to set up an in vitro ischemia/reperfusion model and how to evaluate the effect of stem cell therapy on postischemic cardiac cells.

Stem cell transplantation protocols are finding their way into clinical practice1,2,3. Getting better results, making the protocols more robust, and ...

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method

This protocol shows the measurement of the apoptotic activity neutralization of TNF&#945; in a mouse fibroblast cell model (WEHI 164) using an anti-TNF&#945; mAb. In addition, this protocol can be used to evaluate other anti-TNF&#945; molecules, such as fusion proteins. The cellular model employed here is sensitive to TNF&#945;-mediated apoptosis when an additional stress factor is induced in cell culture conditions (e.g., serum deprivation). This procedure exemplifies how to execute this analytical assay, highlighting the key operations relating to the sample preparation, cell dilution, apoptosis induction, and spectrophotometric measurements that are critical to ensure successful results. This protocol reveals the best-performance conditions relating to apoptosis induction and efficient signal recording, leading to low uncertainty values.

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method

A protocol for the determination of the relative anti-apoptotic activity of an anti-TNF&#945; mAb using a neutralization mechanism with WEHI 164 cells is presented here. This protocol is useful for comparing the neutralization strength of different molecules with the same biological functionality.

This protocol shows the measurement of the apoptotic activity neutralization of TNF&#945; in a mouse fibroblast cell model (WEHI 164) using an ...

Neonatal Murine Cochlear Explant Technique as an In Vitro Screening Tool in Hearing Research

While there have been remarkable advances in hearing research over the past few decades, there is still no cure for Sensorineural Hearing Loss (SNHL), a condition that typically involves damage to or loss of the delicate mechanosensory structures of the inner ear. Sophisticated in vitro and ex vivo assays have emerged in recent years, enabling the screening of an increasing number of potentially therapeutic compounds while minimizing resources and accelerating efforts to develop cures for SNHL. Though homogenous cultures of certain cell types continue to play an important role in current research, many scientists now rely on more complex organotypic cultures of murine inner ears, also known as cochlear explants. The preservation of organized cellular structures within the inner ear facilitates the in situ evaluation of various components of the cochlear infrastructure, including inner and outer hair cells, spiral ganglion neurons, neurites, and supporting cells. Here we present the preparation, culture, treatment, and immunostaining of neonatal murine cochlear explants. The careful preparation of these explants facilitates the identification of mechanisms that contribute to SNHL and constitutes a valuable tool for the hearing research community.

Neonatal Murine Cochlear Explant Technique as an In Vitro Screening Tool in Hearing Research

The goal of this protocol is to demonstrate the preparation, culture, treatment, and immunostaining of neonatal murine cochlear explants. The technique can be utilized as an in vitro screening tool in hearing research.

While there have been remarkable advances in hearing research over the past few decades, there is still no cure for Sensorineural Hearing Loss (SNHL), a ...

An In Vitro Approach to Photodynamic Therapy

Photodynamic therapy (PDT) is a medical procedure that involves incubation of an exogenously applied photosensitizer (PS) followed by visible light photoactivation to induce cell apoptosis. The Federal Drug Administration has approved PDT for the treatment of actinic keratosis, and clinical guidelines recommend PDT as a treatment for certain non-melanoma skin cancers and acne vulgaris. PDT is an advantageous therapeutic modality as it is low cost, non-invasive, and associated with minimal adverse events and scaring. In the first step of PDT, a PS is applied and allowed to accumulate intracellularly. Subsequent light irradiation induces reactive oxygen species formation, which may ultimately lead to cell apoptosis, membrane disruption, mitochondrial damage, immune modulation, keratinocyte proliferation, and collagen turnover. Herein, we present an in vitro method to study PDT in an adherent cell line. This treatment protocol is designed to simulate PDT and may be adjusted to studying the use of PDT with various cell lines, photosensitizers, incubation temperatures, or photoactivation wavelengths. Squamous cell carcinoma cells were incubated with 0, 0.5, 1.0, and 2 mM 5-aminolevulinic acid (5-ALA) for 30 min and photoactivated with 417 nm blue light for 1,000 s. The primary outcome measure was apoptosis and necrosis, as measured by annexin-V and 7-aminoactinomycin D flow cytometry. There was a dose-dependent increase in cell apoptosis following thirty-minute incubation of 5-ALA. To achieve high inter-test validity, it is important to maintain consistent incubation and light parameters when performing in vitro PDT experiments. PDT is a useful clinical procedure and in vitro research may allow for the development of novel PSs, optimization of protocols, and new indications for PDT.

An In Vitro Approach to Photodynamic Therapy

Photodynamic therapy (PDT) is a medical procedure that involves incubation of an exogenously applied photosensitizer (PS) followed by visible light photoactivation to induce apoptosis. We present an in vitro PDT protocol designed to simulate PDT that may be used to study differences in PS incubation and light treatment parameters.

Photodynamic therapy (PDT) is a medical procedure that involves incubation of an exogenously applied photosensitizer (PS) followed by visible light ...

Preparation Of Gushukang (GSK) Granules for In Vivo and In Vitro Experiments

Traditional Chinese herbal medicine plays a role as an alternative method in treating many diseases, such as postmenopausal osteoporosis (POP). Gushukang (GSK) granules, a marketed prescription in China, have bone-protective effects in treating POP. Before administration to the body, one standard preparation procedure is commonly required, which aims to promote the release of active constituents from raw herbs and enhance the pharmacological effects as well as therapeutic outcomes. This study proposes a detailed protocol for using GSK granules in in vivo and in vitro experimental assays. The authors first provide a detailed protocol to calculate the animal-appropriate dosages of granules for in vivo investigation: weighing, dissolving, storage, and administration. Second, this article describes protocols for micro-CT scanning and the measurement of bone parameters. Sample preparation, protocols for running the micro-CT machine and quantification of bone parameters were evaluated. Third, serum-containing GSK granules are prepared, and drug-containing serum is extracted for in vitro osteoclastogenesis and osteoblastogenesis. GSK granules were intragastrically administered twice per day to rats for three consecutive days. Blood was then collected, centrifuged, inactivated, and filtered. Finally, serum was diluted and used for performing osteoclastogenesis and osteoblastogenesis. The protocol described here can be considered a reference for pharmacological investigations of herbal prescription medicines, such as granules.

Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments

This article provides a detailed protocol for preparing a working solution of Gushukang granules for animal studies and GSK granule containing serum for in vitro experiments. This protocol can be applied to pharmacological investigations of herbal medicines as well as prescriptions for both in vivo and in vitro experiments.

Traditional Chinese herbal medicine plays a role as an alternative method in treating many diseases, such as postmenopausal osteoporosis (POP). Gushukang ...

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Primaquine (PMQ), an important anti-malarial drug, has been recommended by the World Health Organization (WHO) for the treatment of life-threatening infections caused by P. vivax and ovale. However, PMQ has unwanted adverse effects that lead&#160;to acute hemolysis in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. There is a need to develop simple and reliable methods for PMQ determination with the purpose of dosage monitoring. In early 2019, we have reported an UV-Vis and naked-eye based approach for PMQ colorimetric quantification. The detection was based on a Griess-like reaction between PMQ and anilines, which can generate colored azo products. The detection limit for direct measurement of PMQ in synthetic urine is in the nanomolar range. Moreover, this method has shown great potential for PMQ quantification from human serum samples at clinically relevant concentrations. In this protocol, we will describe the technical details regarding the syntheses and characterization of colored azo products, the reagent preparation, and the procedures for PMQ determination.

This protocol describes a novel colorimetric method for antimalarial primaquine (PMQ) detection in synthetic urines and human serums.

Primaquine (PMQ), an important anti-malarial drug, has been recommended by the World Health Organization (WHO) for the treatment of life-threatening ...

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

More than half of heart failure (HF) cases are classified as heart failure with preserved ejection fraction (HFpEF) worldwide. Large animal models are limited for investigating the fundamental mechanisms of HFpEF and identifying potential therapeutic targets. This work provides a detailed description of the surgical procedure of descending aortic constriction (DAC) in Tibetan minipigs to establish a large animal model of HFpEF. This model used a precisely controlled constriction of the descending aorta to induce chronic pressure overload in the left ventricle. Echocardiography was used to evaluate the morphological and functional changes in the heart. After 12 weeks of DAC stress, the ventricular septum was hypertrophic, but the thickness of the posterior wall was significantly reduced, accompanied by dilation of the left ventricle. However, the LV ejection fraction of the model hearts was maintained at &gt;50% during the 12-week period. Furthermore, the DAC model displayed cardiac damage, including fibrosis, inflammation, and cardiomyocyte hypertrophy. Heart failure marker levels were significantly elevated in the DAC group. This DAC-induced HFpEF in minipigs is a powerful tool for investigating molecular mechanisms of this disease and for preclinical testing.

The present protocol describes a step-by-step procedure to establish a minipig model of heart failure with preserved ejection fraction using descending aortic constriction. The methods for evaluating cardiac morphology, histology, and function of this disease model are also presented.

More than half of heart failure (HF) cases are classified as heart failure with preserved ejection fraction (HFpEF) worldwide. Large animal models are ...

In Vitro Application of a Wireless Sensor in Flexion-Extension Gap Balance of Unicompartmental Knee Arthroplasty

Unicompartmental knee arthroplasty (UKA) is an effective treatment for end-stage anteromedial osteoarthritis (AMOA). The key to UKA is the flexion-extension gap balance, which is closely related to postoperative complications such as bearing dislocation, bearing wear, and arthritis progression. The traditional gap balance assessment is performed by indirectly sensing the tension of the medial collateral ligament by a gap gauge. It relies on the surgeon's feel and experience, which is imprecise and difficult for beginners. To accurately assess the flexion-extension gap balance of UKA, we developed a wireless sensor combination consisting of a metal base, a pressure sensor, and a cushion block. After osteotomy, the insertion of a wireless sensor combination allows the real-time measurement of intra-articular pressure. It accurately quantifies the flexion-extension gap balance parameters to guide further femur grinding and tibia osteotomy, to improve the accuracy of gap balance. We conducted an in vitro experiment with the wireless sensor combination. the results showed that there was a difference of 11.3 N after applying the traditional method of flexion-extension gap balance performed by an experienced expert.

In Vitro Application of a Wireless Sensor in Flexion-Extension Gap Balance of Unicompartmental Knee Arthroplasty

This protocol presents a cadaveric study of a wireless sensor used in medial unicompartmental knee arthroplasty. The protocol includes the installation of an angle measuring device, standardized Oxford unicompartmental knee arthroplasty osteotomy, preliminary assessment of flexion-extension balance, and application of the sensor to measure flexion-extension gap pressure.

Unicompartmental knee arthroplasty (UKA) is an effective treatment for end-stage anteromedial osteoarthritis (AMOA). The key to UKA is the ...

Microscopic Characterization and TLC-Based Identification of &lt;em&gt;Rhodiola crenulate&lt;/em&gt;

Field Collection and Laboratory Routine Identification of Rhodiola crenulata

The identification of medicinal materials is the premise and guarantee of drug safety. The majority of scientific researchers are bound to favor the simple, fast, effective, and inexpensive identification process of herbals. Rhodiola crenulata is a traditional Tibetan medicine grown at high altitudes, mainly distributed in Tibet, Yunnan, and Sichuan regions of China. Rhodiola crenulate possesses multiple bioactivities, such as anti-inflammatory, anti-hypoxia, and antioxidant properties, and has great potential for development. With the increasing market demand and a rapid decrease in resource content, a large number of confused products of Rhodiola crenulata have been troubling people. Therefore, this protocol introduces a standard process for the identification of Rhodiola crenulata in the field combined with routine laboratory testing. The combination of habitat, microscopic features, and thin-layer chromatography will undoubtedly identify Rhodiola crenulata quickly, efficiently, and economically, contributing to the continuous development of Tibetan medicine and the quality control of medicinal materials.

Author Spotlight: Developing Identification Methods for &lt;em&gt;Rhodiola crenulata&lt;/em&gt; and Investigating Its Resource Distribution and Pharmacological Effects

Here, we describe the identification of Rhodiola Crenulata from habitat, plant morphology, medicinal properties, microscopic features, and thin-layer chromatography.

The identification of medicinal materials is the premise and guarantee of drug safety. The majority of scientific researchers are bound to favor the ...

Analyzing Tibetan Medicinal Plant APB Using 2D-HPLC-MS with Molecular Networking

2D-HPLC-MS Technology Combined with Molecular Network for the Identification of Components in Tibetan Medicine Aconitum pendulum

In this study, a comprehensive approach was employed, utilizing 2D-HPLC-MS technology in conjunction with the molecular network to unravel the intricate chemical composition of the Tibetan medicinal plant APB. Through the implementation of 2D-HPLC, enhanced separation of complex mixtures was achieved, enabling the isolation of individual compounds for subsequent analysis. The molecular network approach further aided in elucidating structural relationships among these compounds, contributing to the determination of potential bioactive molecules. This integrated strategy efficiently identified a wide array of chemical components present within the plant. The findings revealed a diverse spectrum of chemical constituents within APB, including alkaloids, among others. This research not only advances understanding of the phytochemical profile of this traditional Tibetan medicine but also provides valuable insights into its potential therapeutic properties. The integration of 2D-HPLC-MS and molecular network proves to be a powerful tool for systematically exploring and identifying complex chemical compositions in herbal medicines, paving the way for further research and development in the field of natural product discovery.

Author Spotlight: Integrating 2D-HPLC-MS and Molecular Networking in Natural Medicine Analysis

This study utilizes two-dimensional high-performance liquid chromatography-mass spectrometry (2D-HPLC-MS) technology in conjunction with molecular networking to unravel the intricate chemical composition of the Tibetan medicinal plant Aconitum pendulum Busch (APB). The article provides a detailed protocol for the systematic exploration and identification of complex chemical components of herbal medicines.

In this study, a comprehensive approach was employed, utilizing 2D-HPLC-MS technology in conjunction with the molecular network to unravel the intricate ...